In this issue:
Tulisokibart, anti-TL1A monoclonal antibody, for CD
Association of early UC clearance with long-term outcomes
Outcomes associated with antidepressant use in IBD
NUDT15 testing for preventing thiopurine-induced myelosuppression
ACT for adults with IBD and distress
CMV infection in active UC
Real-world tofacitinib for UC-associated spondyloarthropathies
Associations of obesity with inferior IBD outcomes
Antibiotics targeting adherent invasive E. coli in CD
Tofacitinib vs. vedolizumab for biologicnaïve UC
Please login below to download this issue (PDF)